• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

DTaP-HBV-IPV/Hib 疫苗（欣福来六联疫苗）：在婴儿中的使用指南。

DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™): a guide to its use in infants.

机构信息

Adis, Auckland, New Zealand.

出版信息

Paediatr Drugs. 2012 Oct 1;14(5):337-43. doi: 10.2165/11210000-000000000-00000.

DOI:10.2165/11210000-000000000-00000
PMID:22873778
Abstract

Infanrix hexa™, a diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis, and Haemophilus influenzae type b (Hib) conjugate vaccine, is indicated for primary and booster vaccination of infants. Available clinical data from more than a decade of experience with the vaccine indicate that primary and booster vaccination with Infanrix hexa™ is a safe and useful option for providing protection against the common childhood diseases of diphtheria, tetanus, poliomyelitis, pertussis, hepatitis B, and disease caused by Hib.

摘要

欣福立适（六联疫苗）是一种包含白喉、破伤风、无细胞百日咳、乙型肝炎、灭活脊髓灰质炎和乙型流感嗜血杆菌（Hib）的联合疫苗，适用于婴儿的基础免疫和加强免疫。十多年来使用该疫苗的临床数据表明，使用欣福立适（六联疫苗）进行基础免疫和加强免疫是预防白喉、破伤风、脊髓灰质炎、百日咳、乙型肝炎和由 Hib 引起的疾病的安全有效选择。

相似文献

1
DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™): a guide to its use in infants.DTaP-HBV-IPV/Hib 疫苗（欣福来六联疫苗）：在婴儿中的使用指南。
Paediatr Drugs. 2012 Oct 1;14(5):337-43. doi: 10.2165/11210000-000000000-00000.
2
Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).关注 DTPa-HBV-IPV/Hib 疫苗（欣安立适）。
BioDrugs. 2010 Oct 1;24(5):299-302. doi: 10.2165/11206690-000000000-00000.
3
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.5 岁时接种过 3、5、11 月龄六联苗（DTaP-HBV-IPV/Hib）的儿童的免疫持久性。
Hum Vaccin Immunother. 2014;10(10):2795-8. doi: 10.4161/21645515.2014.970494.
4
Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region.在为新生儿接种单价乙型肝炎病毒疫苗后，根据现有国家建议，将六价白喉、破伤风、无细胞百日咳、乙型肝炎病毒、灭活脊髓灰质炎和流感嗜血杆菌 b 型结合疫苗进行整合：亚太地区系统评价的结果。
Expert Rev Vaccines. 2019 Sep;18(9):921-933. doi: 10.1080/14760584.2019.1646643. Epub 2019 Aug 1.
5
DTaP5-HB-IPV-Hib Vaccine (Vaxelis): A Review of its Use in Primary and Booster Vaccination.五联疫苗（白喉、破伤风、无细胞百日咳、B型流感嗜血杆菌结合疫苗、灭活脊髓灰质炎疫苗）（Vaxelis）：用于基础免疫和加强免疫接种的综述
Paediatr Drugs. 2017 Feb;19(1):69-80. doi: 10.1007/s40272-016-0208-y.
6
Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine.婴儿的乙型肝炎基础疫苗接种可以使用一种联合的六价白喉-破伤风-无细胞百日咳-乙型肝炎-灭活脊髓灰质炎-乙型流感嗜血杆菌疫苗来完成。
Ann Acad Med Singap. 2007 Oct;36(10):801-6.
7
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌（HIB）联合疫苗与分别接种白喉、破伤风、百日咳、乙型肝炎疫苗和HIB疫苗用于白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌（HIB）的一级预防。
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD005530. doi: 10.1002/14651858.CD005530.pub3.
8
Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib.4至6岁及7至9岁儿童在婴儿期曾接种六价白百破-乙肝-脊灰灭活疫苗/ Hib疫苗后的免疫持久性。
Hum Vaccin. 2010 Feb;6(2):189-93. doi: 10.4161/hv.6.2.10117.
9
A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and type b invasive infections (DTaP-IPV/Hib) in South Korean infants.一项针对韩国婴儿的葛兰素史克联合疫苗（预防白喉、破伤风、百日咳、脊髓灰质炎和乙型侵袭性感染）的前瞻性、观察性、多中心、上市后安全性监测研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2406060. doi: 10.1080/21645515.2024.2406060. Epub 2024 Oct 8.
10
Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.与已获许可的六联疫苗（Infanrix hexa）相比，六价白喉-破伤风-无细胞百日咳-乙肝-脊髓灰质炎- b型流感嗜血杆菌联合疫苗（DTPa-HBV-IPV/Hib）中两种研究用白喉、破伤风和b型流感嗜血杆菌抗原制剂进行初次和加强免疫接种的免疫原性和安全性。
Hum Vaccin Immunother. 2017 Jul 3;13(7):1505-1515. doi: 10.1080/21645515.2017.1294294. Epub 2017 Mar 24.

引用本文的文献

1
Better adherence to childhood Haemophilus influenzae type b vaccination with combination vaccines compared to single-antigen vaccines: Evidence from China.与单价疫苗相比，结合疫苗能更好地提高儿童对乙型流感嗜血杆菌疫苗的接种依从性：来自中国的证据。
J Glob Health. 2023 Aug 25;13:04080. doi: 10.7189/jogh.13.04080.
2
Induced immunity against hepatitis B virus.诱导的抗乙型肝炎病毒免疫力。
World J Hepatol. 2015 Jun 28;7(12):1660-70. doi: 10.4254/wjh.v7.i12.1660.
3
The value of childhood combination vaccines: From beliefs to evidence.儿童联合疫苗的价值：从观念到证据。

本文引用的文献

1
Immunogenicity of a hexavalent vaccine co-administered with 7-valent pneumococcal conjugate vaccine. Findings from the National Immunisation Programme in The Netherlands.六价疫苗与 7 价肺炎球菌结合疫苗联合接种的免疫原性。荷兰国家免疫规划的发现。
Hum Vaccin Immunother. 2012 Jun;8(6):743-8. doi: 10.4161/hv.19642. Epub 2012 Apr 17.
2
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.在 3、5 和 11 个月龄时接种欣安立适®六联疫苗的免疫原性。
Vaccine. 2012 Apr 5;30(17):2710-4. doi: 10.1016/j.vaccine.2012.02.024. Epub 2012 Feb 18.
3
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.
Hum Vaccin Immunother. 2015;11(9):2132-41. doi: 10.1080/21645515.2015.1044180.
当与 13 价肺炎球菌结合疫苗同时使用时，含白喉类毒素、破伤风类毒素、无细胞百日咳、乙型肝炎、灭活脊髓灰质炎病毒和 b 型流感嗜血杆菌的联合疫苗的免疫原性。
Vaccine. 2011 Aug 11;29(35):6042-8. doi: 10.1016/j.vaccine.2011.06.026. Epub 2011 Jun 23.
4
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12-23-month-old children.在 12-23 个月龄儿童中，与 Infanrix ？六联疫苗联合使用的四价脑膜炎奈瑟菌血清群 A、C、W-135 和 Y-破伤风类毒素结合疫苗具有免疫原性，且安全性特征良好。
Vaccine. 2011 Jun 6;29(25):4264-73. doi: 10.1016/j.vaccine.2011.03.009. Epub 2011 Mar 21.
5
Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe.在欧洲的接种计划下，人轮状病毒疫苗 Rotarix 与常规婴儿疫苗联合使用的免疫原性和安全性。
Vaccine. 2010 Jul 19;28(32):5272-9. doi: 10.1016/j.vaccine.2010.05.057. Epub 2010 Jun 9.
6
DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.DTaP-HBV-IPV/Hib 联合疫苗（百白破-乙肝-脊灰- Hib 联合疫苗）：作为基础和加强免疫接种的应用评价。
Drugs. 2010 May 28;70(8):1021-58. doi: 10.2165/11204830-000000000-00000.
7
Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life.在儿童期首针和第 2 针基础免疫接种 DTPa-HBV-IPV/Hib 4 剂后，对乙型肝炎的持久免疫记忆。
BMC Infect Dis. 2010 Jan 15;10:9. doi: 10.1186/1471-2334-10-9.
8
Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib.4至6岁及7至9岁儿童在婴儿期曾接种六价白百破-乙肝-脊灰灭活疫苗/ Hib疫苗后的免疫持久性。
Hum Vaccin. 2010 Feb;6(2):189-93. doi: 10.4161/hv.6.2.10117.
9
Booster vaccinations: can immunologic memory outpace disease pathogenesis?加强疫苗接种：免疫记忆能超过疾病发病机制吗？
Pediatrics. 2009 Dec;124(6):1633-41. doi: 10.1542/peds.2008-3645. Epub 2009 Nov 23.
10
Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine.对婴儿期接种四剂六联白百破-乙肝-脊灰- Hib疫苗的4至9岁儿童的乙肝病毒免疫记忆。
Hum Vaccin. 2009 Sep;5(9):592-8. doi: 10.4161/hv.9051. Epub 2009 Sep 20.